Spanish Red Biotech Pipeline

IRYCIS

New aptamers against HCV

Type: Biomarkers / Diagnostic
Therapeutic area: Infections
Indication: C hepatitis
Phase: 2Preclinical Validation, 1R+D
Studies location: